Reagents and instruments for immunology, cell biology and molecular biology.
 

Biorbyt

  See all products
  Brochures
  Videos
 
Website: 
https://www.biorbyt.com
 
SARS-CoV-2 - Duvelisib - Therapeutic Candidates

SARS-CoV-2 - Duvelisib - Therapeutic Candidates

Search result : 38 product found

Refine your search :

RUOCE / IVD
  • Unconjugated 5
  • Biochemicals 33
  • Inhibitor/Antagonist/Agonist 5
APPLY FILTERS
REINITIALIZE


Cat#
Description
Cond.
Price Bef. VAT
orb636839-5mg
Duvelisib [1201438-56-3]
 5mg 
orb636839-25mg
Duvelisib [1201438-56-3]
 25mg 
orb1306832-25mg
Duvelisib [1201438-56-3]
 25mg 
orb1306832-50mg
Duvelisib [1201438-56-3]
 50mg 
orb1306832-100mg
Duvelisib [1201438-56-3]
 100mg 
orb1306832-5mg
Duvelisib [1201438-56-3]
 5mg 
orb1306832-2mg
Duvelisib [1201438-56-3]
 2mg 
orb1306832-10mg
Duvelisib [1201438-56-3]
 10mg 
orb1738678-25mg
Duvelisib hydrate [1386861-49-9]
 25mg 
orb1738678-100mg
Duvelisib hydrate [1386861-49-9]
 100mg 
orb1738678-50mg
Duvelisib hydrate [1386861-49-9]
 50mg 
orb1709814-1ml
Duvelisib (R enantiomer) hydrochloride
 1mL*10mM(inDMSO) 
orb1709814-10mg
Duvelisib (R enantiomer) hydrochloride
 10mg 
orb1709814-100mg
Duvelisib (R enantiomer) hydrochloride
 100mg 
orb1101902-20mg
Duvelisib (IPI-145) [[1201438-56-3]]
 20mg 
orb1709814-50mg
Duvelisib (R enantiomer) hydrochloride
 50mg 
orb1709814-25mg
Duvelisib (R enantiomer) hydrochloride
 25mg 
    ‹
    ›